Alisa is a member of the Practice Area Corporate / M&A. She is specialized on national and cross-border M&A- and private equity-transactions and advises on the buy-side as well as on the sell-side. In addition, she advises on general corporate law issues.
She represents a wide range of clients, including German and international companies and financial investors. A particular focus of her practice is on the sectors life sciences and health care.
|Since 2022||Senior Associate, Taylor Wessing|
|2018 - 2022||(Senior) Associate, CMS Hasche Sigle, Frankfurt am Main|
|2016 - 2018||Research assistant and trainee lawyer, Linklaters, Frankfurt am Main und Hong Kong|
|2018||Admission as Attorney at Law|
|2018||Award of the additional qualification in pharmaceutical law, Philipps-Universität Marburg|
|2018||Second state examination in law, Higher Regional Court of Frankfurt am Main|
|2015||First state examination in law, Philipps-Universität Marburg|
|2008 - 2009||Law studies, Faculté Jean-Monnet, Université Paris-Sud, Paris|
Taylor Wessing advises International Chemical Investors Group on acquisition of inprotec AG
Higher Regional Court of Hamm on the advertising ban in Sec. 12 HWG in the context of the COVID 19 pandemic
Taylor Wessing advises Emerald Technology Ventures on investment in Colibri Energy
With this investment, Emerald Technology Ventures supports the development and growth of Colibri Energy, a provider of lithium-ion battery systems for vehicles in airport and industrial logistics.
OLG Celle on the obligations of distributors under Art. 14 MDR when distributing non-compliant medical devices in the context of unfair competition law
Dr. Kian Böhmer
Dr. Oliver Klöck
Karolina Lange-Kulmann, LL.M. (Medizinrecht)
Dr. Vanessa Christin Vollmar